MBK’s proposed buyout of pharmaceutical company uncertain
The Asian private equity firm’s S$357 million bid for AsiaPharm faces opposition from minority shareholders.
4 January 2013•1 min read
The Asian private equity firm’s S$357 million bid for AsiaPharm faces opposition from minority shareholders.
